4 drug(s) with this reaction
4,616 total reports
Surgery has been reported as an adverse reaction across 4 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,616 adverse event reports mention surgery in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with surgery, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have surgery listed in their FDA adverse event reports, sorted by report count:
In addition to surgery, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
4 drug(s) manufactured by Abbvie Inc have surgery listed in their FDA adverse event reports: UPADACITINIB, RISANKIZUMAB-RZAA, PANCRELIPASE, ATOGEPANT.
There are a combined 4,616 reports of surgery across 4 Abbvie Inc drug(s) in the FDA adverse event database.